chrisvoncsefalvay/vaers-outcomes huggingface dataset:
12 hours after my dose (on Saturday), going to bed at 10:30 and tired, I began to feel a low-grade temperature set in, and I woke up 2 hours later during the night and was having soreness in my lower back as the most pronounced.  I had trouble sleeping through most of the night and got up twice to urinate.  I could not get comfortable enough to fall asleep - was not necessarily feeling pain, just soreness.  During the day Sunday, I tried to rest having lost sleep, and it was mainly my lower back (back strap muscles) which were experiencing soreness.  Sunday evening, I went to bed around 9:30, and I woke up around midnight having a sore neck.  It felt like I was not necessarily sore in the muscles, but I could feel my heart rate increase and my blood pumping through my neck to my brain.  I could not get comfortable at all and lost sleep.  During the day Monday, I tried to rest it off, and there was no position I could rest where I was not in pain in my neck.  It almost felt like I had some form of encephylitis.  I went to bed around 8:30 PM, exhausted.  Woke up around midnight again, and I could not get back to sleep until 4 AM.  I found a position where my head turned and my shoulder extended away was not painful.  I woke up having felt like I had strained that muscle however.
Suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Zostavax (received a dose on an unknown date).   On an unknown date, the patient received the 2nd dose of Shingrix and the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix and Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix and Shingrix.  Additional details were provided as follows The patient had reported for him/herself. The age at vaccination was not reported. The patient received Zostavax and both the doses of Shingrix, and the patient still got shingles. This case was considered as suspected vaccination failure, since the details regarding time to onset for event and laboratory confirmation of shingles were not provided.
On Day 5 after first shot I had extreme pain in injection site that was red swollen and hot. Also my left armpit was so swollen there was no longer a visible armpit. This has lasted for a few days now.
3 hours after injection- headache and dizziness. 8 hours post injection; nausea, diarrhea, temperature, chills, muscle pain, malaise, worsening headache. Flet like flu like symptoms. AE's lasted into the late afternoon with some relief of most symptoms but diarrhea every 30 minutes.. The next day 1/7/2021; fever still present at 100.9, and malaise as well as fatigue and muscle pain- though decreased from the day before. About 30 hours after injection- vomiting started ocurring. Vomiting subsided about 5 hours later with continued nausea. As of 1/7/2021 @16:04 temperature, nausea, muscle pain, fatigue, and malaise still continuing.
Patient given Pfizer 6 mo to 4yr vaccine. Vaccine not diluted prior to administering.
Increased volume of menstrual flow after 1st dose; This is a spontaneous report received from a contactable consumer (patient). A 51-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: ER8730), via an unspecified route of administration, administered in Right arm on 29Mar2021 11:00 AM (at age of 51 years old) as single dose for COVID-19 immunization. Relevant medical history included: Acid reflux, Occasional nausea, Heavy periods. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication included ethinylestradiol, ferrous fumarate, norethisterone acetate (LO LOESTRIN FE). The patient previously took pheneticillin potassium (PENICILLIN) and had allergy. The patient experienced increased volume of menstrual flow after 1st dose on 29Mar2021 04:00 PM. No treatment received for the adverse event. The outcome of the event was Recovered in 2021.  No follow-up attempts are needed. No further information is expected.
?Covid arm?. Swelling and itching in left arm at injection site one week after injection.  Felt a sharp pain/?pinch? in left armpit starting two days prior to appearance of swelling. Swelling currently feels the size of a small chicken egg. Armpit still feels slightly ?pinched? and movement in that armpit feels very slightly restricted. Swelling sore is itchy and red, although it is currently hard to tell if the redness is from scratching or inherent to the area.
Seven days post MMR had a temp of 101 deg. F. and broke out with full body rash and started with bilat eye to right side only while eating. No shaking or jerking movements. Seen in ER, referred to neurologist which states non seizure, MMR reaction.
suspected vaccination failure; In 2020 he developed shingles; This case was reported by a consumer via call center representative and described the occurrence of suspected vaccination failure in a 82-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix and the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix and Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was recovered/resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix and Shingrix.  Additional details were provided as follows: The reporter was the patient. The reporter stated that, the patient received Shingrix series in 2018 and in 2020 developed shingles. The patient inquiring about getting shingrix vaccine series for a second time for shingles prevention. The reporter did not consent to follow up. This case was considered to be a suspected vaccination failure case, as the details regarding laboratory confirmation for shingles was unknown.
Bilateral moderate tinnitus starting around 8 hours after the second Pfizer shot. Still present with no improvement 10 days after  injection. No treatment has been given.
psoriasis- not curable went to dermatologist. Dr gave me prescription cream specifically for psoriasis and it got worse still trying to get care for that no apt till september 2022 had a lingering cough went to Dr. office  finally went away on its own after about a year had shortness of breath and minor chest pain went to Dr office did an ekg ended up in the hospital high bp and pulse and doctoring with a cardiologist
Patient received vaccine 5/23; by 5/25 had red knot at injection site. On 5/26 patient had nodule of pus in arms and started antibiotics. On 5/28, patient is recovering.
Information has been received on 27-NOV-2018 regarding a case in litigation from a lawyer concerning a female patient of unknown age. There was no information provided regarding the patient's concurrent conditions, medical history or concomitant medications. In or around 22-NOV-2016, the patient received the ZOSTAVAX for its intended purpose: the prevention of shingles. Shortly thereafter, the patient suffered throbbing with occasional radiating muscle pain, numbness, difficulty swallowing, rash, and nausea. In or around December of 2016, the patient presented to an urgent care for these injuries and was diagnosed with an unspecified viral infection. In or around December of 2016, the patient presented to her physician for worsening of the same injuries and was diagnosed with shingles. As a direct and proximate result of ZOSTAVAX the patient's symptoms have resulted in physical limitations and pain not present prior to using ZOSTAVAX. The patient also experiences mental and emotional distress due to resulting physical limitations and seriousness of her condition. As a result of ZOSTAVAX, the patient sustained severe and lasting personal injuries. Further, as a tragic consequence of ZOSTAVAX, the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. The patient has incurred and will continue to incur medical expenses and other economic harm as a direct result of use of ZOSTAVAX. Numbness, difficulty swallowing, nausea, shingles and unspecified viral infection were considered to be disabling. Additional information has been requested.
General weakness in extremities.  Fell in garage and wasn?t discovered for several hours.  Brought into house and wrapped in blankets, etc., fed warm oatmeal.  Stumbled around for the evening, but slept well.  Woke up with a fever of 100  degrees.  Now normal temp.
SkinRash Vaccinated with 2nd dose @ 0942 w/o issue. After she returned to work, c/o rash to chest and arms. At 1500 returned to the immunization clinic. Take to ED for evaluation BP 224/108, 88, 18, 97% O2sat. Narrative:  Vaccinated with 2nd dose @0942 w/o issue. 5 hours later at 1500 returned to the immunization clinic with c/o rash to chest and arms and c/o slight H/A. BP elevated. Taken to ED for evaluation BP 224/108, 88, 18, 97% O2sat.
pt vax & exp redness & swelling from the inj site to elbow; soreness & redness also occurred in the shoulder area; pt exp subsided in 3-4 days;
Erythema, swelling and warm to touch. Blister at injection site. Entire upper thigh swollen.
rash; allergic reaction; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a 68 year old female patient. Information on the patient's concurrent conditions, medical history or concomitant therapy was not reported. On 04-APR-2017, the patient was administered zoster vaccine live (ZOSTAVAX) (dose, route of administration, lot# and expiration date were not reported). As a result of her receipt of zoster vaccine live (ZOSTAVAX), on 11-APR-2017, patient was caused to suffer an allergic reaction and rash, including any and all of its sequelae. As a result of her receipt of zoster vaccine live (ZOSTAVAX), patient has been caused to suffer severe personal injuries, pain, suffering, and emotional distress, as well as to incur substantial economic damages. As a result of the foregoing acts and omissions, patient was caused to suffer serious and dangerous side effects including an allergic reaction and rash, as well as other severe and personal injuries which are permanent and lasting in nature, physical pain and mental anguish, including diminished enjoyment of life, as well as the need for lifelong medical treatment, monitoring and/or medications. As a result of the foregoing acts and omissions, patient requires and/or will require more health care and services and did incur medical, health, she will in the future be required to obtain further medical and/or hospital care, attention, and services. As a foreseeable, direct, and proximate consequence of Company's actions, omissions, and misrepresentations, patient suffered an allergic reaction and rash and other related health complications. In addition, patient requires and will continue to require healthcare and services. Patient has incurred and will continue to incur medical and related expenses. Patient also has suffered and will continue to suffer diminished capacity for the enjoyment of life, a diminished quality of life, increased risk of premature death, aggravation of preexisting conditions, activation of latent conditions, and other losses and damages. Patient's direct medical losses and costs include physician care, monitoring, and treatment. Patient has incurred and will continue to incur mental and physical pain and suffering. The outcome of rash and hypersensitivity was reported as not recovered/not resolved. The reporter considered rash and hypersensitivity to be related to Zoster Vaccine Live (ZOSTAVAX).     Allergic reaction and rash were considered to be disabling.
This spontaneous report was received from a medical assistant and refers to multiple patients of unknown age and gender. No information regarding the patients' concurrent conditions, medical history and concomitant therapies was reported. On unknown dates, the patients received incorrectly stored doses of PNEUMOVAX23 (dose and route of administration were not reported) lot # L048264, expiration date: 10-JUN-2017. No adverse effects were reported. The vaccines were stored in the temperature between 47 and 77 degrees Fahrenheit for 3 hours 15 minutes. The temperature excursion was detected by a 'Digital Data Logger'. Vaccines underwent previous temperature excursion: they were stored in temperature between 47 and 77 degrees Fahrenheit for 3 hours 30 minutes. Additional information has been requested.
Breakthrough case admission after two Janssen vaccines Janssen 3/12/21 Lot# 1805020;  Janssen 11/18/21 Lot# 1855191
This spontaneous report was received from a registered nurse and refers to an unspecified number of patients of unknown age and gender. On an unknown dates the patients may have been vaccinated with unknown number of improperly stored VARIVAX of lot # M012990, expiry: 14-MAR-2018 after temperature excursion of 7 hours, 48 minutes to a maximum of 20.9 Fahrenheit (F). This vaccine lot had no previous excursions. In addition the reporter stated that on an unknown date, the patients may have been vaccinated with improperly stored doses of VARIVAX of lot#: L050956, expiry: 17-DEC-2017 for which excursion occurred for 7 hours, 48 minutes to a maximum of 20.9 Fahrenheit (F). Multiple prior excursion for unspecified vaccine were reported of 3 hours 49 minutes to a maximum of 7.9 F, 28F for 4.5 hours, 9.9 F for 8 hours 47 minutes, 12.4 F for 17 hours 40 minutes, 16.2 F for 17 hours 33 minutes and 14.8 F for 10 hours and 14 minutes. There were no adverse effects reported. No additional information available. This is one of two reports received from the same source. Additional information has been requested.
Information has been received from a registered nurse concerning an unspecified number of patients who on an unspecified date was vaccinated with GARDASIL vaccine (yeast) (route and administrating site not reported). Subsequently, the patients experienced pain at the injection site. This one of several reports from the same source. Attempts made to obtain additional identifying information to distinguish the individual patients mentioned in the report were unsuccessful. Additional information is not expected.
Severe whole body aches (18 days so far); fevers (102.0) for many days; headaches, severe pain in left arm (up and down) numbness, nausea, heart racing.
Generalized body ache and fever chills; Generalized body ache and fever chills; Generalized body ache and fever chills; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 53-years-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID -19 VACCINE, Solution for injection, Lot Number and Expiration date not reported) via an unspecified route of administration, administered in left arm on 22Mar2021 14:45 (age at vaccination: 53-years-old) as dose 2, single for COVID-19 immunization (clinic). The patient medical history and concomitant medications was not reported. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID -19 VACCINE, Solution for injection, Lot Number and Expiry date not reported) via an unspecified route of administration, administered in left arm on 01Mar2021 15:15 as dose 1, single for COVID-19 immunization (age at vaccination: 53-years-old). Patient had no covid prior to vaccination and not tested for covid post vaccination. Patient had no other vaccine in four weeks. On 23Mar2021 12:00, the patient experienced generalized body ache and fever chills. The patient had not received treatment for the events. The outcome of the events was reported as recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Systemic: Chills-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Hypotension-Mild, Systemic: Nausea-Mild, Systemic: Weakness-Mild
Client reports weakness in left arm and "tingling in hand "with difficulty  gripping. States she had a severe adverse reaction in October to a flu vaccine however reports symptoms not the same. Client also could not recall if the flu vaccine was given in the same arm she is experiencing discomfort.
2nd day hard swollen red patch at injection site, half dollar size. Muscle aches and joint pain. 3rd day redness spread on arm. Rash under breasts.
I heard air when I pushed the syringe barrel. The syringe emptied, but there was clear fluid running down her arm. I repeated the dose so that she would be fully vaccinated.
Headache; Dizziness; injection site pain and redness; injection site pain and redness; Dose 1 start date: 15Jun2021/ Dose 2 start date: 08Aug2021.; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FA7484) via an unspecified route of administration in the left arm on 08Aug2021 at 16:15 (at the age of 28-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included bupropion (MANUFACTURER UNKNOWN), naltrexone (MANUFACTURER UNKNOWN) and ethinylestradiol; norethisterone acetate (JUNEL), all from unknown dates for unknown indications and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0180) via an unspecified route of administration in the left arm on 15Jun2021 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. On 08Aug2021 at 17:15, the patient experienced headache, dizziness, injection site pain and redness. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, dizziness, injection site pain and redness was not recovered at the time of this report.
35 Y.O. female patient recieved Moderna booster on 7/28/22 @ 1605. Prior recieving the vaccine the patient told the vaccinator that she had a panic attack with her 1st dose vaccine and she was transferred to the ER. Patient didn't mention anything about recieving EPI PEN with her 1st dose. Patient recieved the vaccine on the gurney and was recommended to wait at least 15 min to check her vital signs prior leaving the clinic. At 1607 patient stated she's not feeling good and she's not able to breathe, Paient's face was swollen and red. At 1607 EPI PEN 0.3 mg and Benadryl IM 50mg/1ml was given to the patient. O2 at 6l/min via NC applied. Pt's respiration were even and unlabored. Skin color warm and dry. Her capillary refill was less than 2 sec. Patient's vital signs were as the following: At 1609 BP 173/90, HR 114, O2 (unable to get a readfing, patient had long acrelyic nails acrylic nails on toes as well we have tried her earlobes with no success). At 1611 BP 149/88 HR 117 O2 (no reading), At 1615  BP 174/84 HR 128 O2 (no reading). At 1607 emergency number was called.
she had pain at the injection site that started at night, the day she received the vaccine (03MAY2021), and it was sore the next day; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (she had pain at the injection site that started at night, the day she received the vaccine (03MAY2021), and it was sore the next day) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included FAMOTIDINE for GERD, CALCIUM, MAGNESIUM, COPPER, ZINC, VITAMIN D [VITAMIN D NOS], OMEGA-3 NOS, MENAQUINONE-7 (K2) and PROBIOTICS NOS for an unknown indication.    On 03-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-May-2021, the patient experienced INJECTION SITE PAIN (she had pain at the injection site that started at night, the day she received the vaccine (03MAY2021), and it was sore the next day). At the time of the report, INJECTION SITE PAIN (she had pain at the injection site that started at night, the day she received the vaccine (03MAY2021), and it was sore the next day) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       treatment to the events not provided.
First shot not listed on 4/27/2021: Sore arm first 30 hrs, between 30-57 hrs I had fever, Euphoria, bad muscle aches for up to 70 hrs. Second shot on 5/18/2021: No arm soreness, Fever, Sever body aches, and Euphoria started/lasted 12-72 hours after injection.  Started developing calf cramping around 24 hrs and continued to have minor bruising in both calf muscles starting around 72 hours continuing for up to a next few weeks. Calf discomfort/cramping started subsiding around a 3-4 weeks after shot but developed severe hamstring bruising (possibly clotting) around June 20 (roughly 1 month after second shot).  By second week in July bruising was gone, still have minor discomfort in both calfs but only right leg hamstring discomfort.  Only other side effect has been more frequent headaches (usually daily).  I do have some bruising pictures if needed.